Vered Caplan

Vered Caplan has an engineering background and is the CEO of Orgenesis, a biotech portfolio company focused on making advanced therapies more accessible and available via a decentralized approach. She is actively involved in expanding a global network that aligns industry, academia, hospitals and governments to standardize the production and supply of cell and gene therapies to achieve the goals of affordability and availability. Prior to coming to Orgenesis in 2014, Ms. Caplan held a variety of entrepreneurial positions at various medical device and biotech companies for more than two decades.